Research Papers
A curated document list highlighting the utility and performance of LiverMultiScan
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Understanding complexity
Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease.
Read moreUnderstanding complexity
Longitudinal Changes in Quantitative Magnetic Resonance Imaging Metrics in Children and Young Adults with Autoimmune Liver Disease
Read moreValidation studies
Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases
Read moreValidation studies
Clinical utility of MRI biomarkers for identifying NASH patients at high risk of progression: A multi-center pooled data and meta-analysis
Read moreMaking patients better
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
Read moreUnderstanding complexity
Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease
Read moreValidation studies
Quantitative multiparametric MRI can aid NASH diagnosis in a Japanese cohort
Read moreValidation studies
Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis
Read morePredicting outcomes
Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease
Read moreMaking patients better
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis
Read moreValidation studies
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease
Read moreValidation studies
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
Read moreUnderstanding complexity
Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis
Read moreMaking patients better
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
Read morePredicting outcomes
Multiparametric magnetic resonance imaging for the assessment of nonalcoholic fatty liver disease severity
Read moreMaking patients better
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
Read moreMaking patients better
A low energy totel diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis
Read moreUnderstanding complexity
Novel multimetric MRI detects improved future liver remnant quality post-dual vein embolization
Read moreValidation studies
Decreases in cT1 and liver fat content reflect histological improvement induced by therapies in MASH: a multicentre pooled cohort analysis
Read moreValidation studies
Quantitative MRI for monitoring metabolic dysfunction associated steatotic liver disease: A test-retest repeatability study
Read moreUnderstanding complexity
Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy
Read moreMaking patients better
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study
Read moreUnderstanding complexity
Corrected T1 Mapping in Children and Young Adults With Autoimmune Liver Disease: Correlation With Histology
Read moreFull publication list